E. Okur And A. Yerlikaya, "A novel and effective inhibitor combination involving bortezomib and OTSSP167 for breast cancer cells in light of label-free proteomic analysis," CELL BIOLOGY AND TOXICOLOGY , vol.35, no.1, pp.33-47, 2019
Okur, E. And Yerlikaya, A. 2019. A novel and effective inhibitor combination involving bortezomib and OTSSP167 for breast cancer cells in light of label-free proteomic analysis. CELL BIOLOGY AND TOXICOLOGY , vol.35, no.1 , 33-47.
Okur, E., & Yerlikaya, A., (2019). A novel and effective inhibitor combination involving bortezomib and OTSSP167 for breast cancer cells in light of label-free proteomic analysis. CELL BIOLOGY AND TOXICOLOGY , vol.35, no.1, 33-47.
Okur, Emrah, And AZMİ YERLİKAYA. "A novel and effective inhibitor combination involving bortezomib and OTSSP167 for breast cancer cells in light of label-free proteomic analysis," CELL BIOLOGY AND TOXICOLOGY , vol.35, no.1, 33-47, 2019
Okur, Emrah And Yerlikaya, AZMİ. "A novel and effective inhibitor combination involving bortezomib and OTSSP167 for breast cancer cells in light of label-free proteomic analysis." CELL BIOLOGY AND TOXICOLOGY , vol.35, no.1, pp.33-47, 2019
Okur, E. And Yerlikaya, A. (2019) . "A novel and effective inhibitor combination involving bortezomib and OTSSP167 for breast cancer cells in light of label-free proteomic analysis." CELL BIOLOGY AND TOXICOLOGY , vol.35, no.1, pp.33-47.
@article{article, author={Emrah Okur And author={AZMİ YERLİKAYA}, title={A novel and effective inhibitor combination involving bortezomib and OTSSP167 for breast cancer cells in light of label-free proteomic analysis}, journal={CELL BIOLOGY AND TOXICOLOGY}, year=2019, pages={33-47} }